329 related articles for article (PubMed ID: 1409743)
1. Amyloid precursor protein (APP) and beta A4 amyloid in Alzheimer's disease and Down syndrome.
Beyreuther K; Dyrks T; Hilbich C; Mönning U; König G; Multhaup G; Pollwein P; Masters CL
Prog Clin Biol Res; 1992; 379():159-82. PubMed ID: 1409743
[No Abstract] [Full Text] [Related]
2. Alzheimer's disease: genesis of amyloid.
Beyreuther K; Multhaup G; Masters CL
Ciba Found Symp; 1996; 199():119-27; discussion 127-31. PubMed ID: 8915607
[TBL] [Abstract][Full Text] [Related]
3. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
[TBL] [Abstract][Full Text] [Related]
4. [Molecular biology of beta A4 protein and Alzheimer disease].
Charnay Y; Vallet PG; Giannakopoulos P; Hof PR; Bouras C
Rev Neurol (Paris); 1994; 150(6-7):405-12. PubMed ID: 7747007
[TBL] [Abstract][Full Text] [Related]
5. Physiological and pathological interrelationships of amyloid beta peptide and the amyloid precursor protein.
Larner AJ
Bioessays; 1995 Sep; 17(9):819-24. PubMed ID: 8763834
[TBL] [Abstract][Full Text] [Related]
6. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
Botella-López A; Cuchillo-Ibáñez I; Cotrufo T; Mok SS; Li QX; Barquero MS; Dierssen M; Soriano E; Sáez-Valero J
Neurobiol Dis; 2010 Mar; 37(3):682-91. PubMed ID: 20025970
[TBL] [Abstract][Full Text] [Related]
7. Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks beta/A4 amyloid immunoreactivity.
Kametani F; Tanaka K; Ishii T; Ikeda S; Kennedy HE; Allsop D
Biochem Biophys Res Commun; 1993 Mar; 191(2):392-8. PubMed ID: 8460999
[TBL] [Abstract][Full Text] [Related]
8. A molecular approach to Alzheimer's disease.
Multhaup G; Masters CL; Beyreuther K
Biol Chem Hoppe Seyler; 1993 Jan; 374(1):1-8. PubMed ID: 8439394
[No Abstract] [Full Text] [Related]
9. [APP, the causal gene for Alzheimer's disease].
Tamaoka A; Kametani F
Tanpakushitsu Kakusan Koso; 1996 Aug; 41(10):1453-9. PubMed ID: 8741396
[No Abstract] [Full Text] [Related]
10. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
[TBL] [Abstract][Full Text] [Related]
11. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.
Tanzi RE; McClatchey AI; Lamperti ED; Villa-Komaroff L; Gusella JF; Neve RL
Nature; 1988 Feb; 331(6156):528-30. PubMed ID: 2893290
[TBL] [Abstract][Full Text] [Related]
12. Missense mutations associated with familial Alzheimer's disease in Sweden lead to the production of the amyloid peptide without internalization of its precursor.
Essalmani R; Macq AF; Mercken L; Octave JN
Biochem Biophys Res Commun; 1996 Jan; 218(1):89-96. PubMed ID: 8573182
[TBL] [Abstract][Full Text] [Related]
13. Mutations in APP and their role in beta-amyloid deposition.
Fidani L; Goate A
Prog Clin Biol Res; 1992; 379():195-214. PubMed ID: 1409745
[No Abstract] [Full Text] [Related]
14. [Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes].
Fukatsu R; Tsuzuki K; Hayashi Y; Takamaru Y; Sasaki N; Yoshida T; Hatakeyama Y; Fuji N; Takahata N
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):3-11. PubMed ID: 9086357
[TBL] [Abstract][Full Text] [Related]
15. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
16. Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments.
Vetrivel KS; Thinakaran G
Neurology; 2006 Jan; 66(2 Suppl 1):S69-73. PubMed ID: 16432149
[TBL] [Abstract][Full Text] [Related]
17. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
[TBL] [Abstract][Full Text] [Related]
18. The amyloid peptide precursor in Alzheimer's disease.
Octave JN
Acta Neurol Belg; 1995 Dec; 95(4):197-209. PubMed ID: 8553793
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta precursor protein processing in neurodegeneration.
Wilquet V; De Strooper B
Curr Opin Neurobiol; 2004 Oct; 14(5):582-8. PubMed ID: 15464891
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the high affinity heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II).
Multhaup G; Mechler H; Masters CL
J Mol Recognit; 1995; 8(4):247-57. PubMed ID: 8588942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
